News & Articles

AllEventsIndustry NewsTips & Tricks

FDA Rejects Rivoceranib Plus Camrelizumab for Liver Cancer for the Second Time

22 mars 2025

Bayer hit with $2 billion Roundup verdict in US state of Georgia cancer case

23 mars 2020